Memory Weight in AI Compute Indices: The Underweight Correction
2026-10-25
It took 18 months. That's all it took for the first pure-play DRAM ETF to cross $10 billion in assets under management. Launched in early 2025 with modest fanfare—a niche product for a niche audience—the DRAM ETF (ticker: DRAM, hypothetical for this discussion) has become the fastest-growing semiconductor-themed ETF in history. Faster than the AI ETF boom of 2023. Faster than the EV ETF surge of 2021. Faster than the cannabis ETF frenzy of 2018.
This post explores the DRAM ETF's milestone from multiple angles. We'll examine why it resonated with investors, assess what it means for AI storage and computing themed products, compare it to existing alternatives (HBM ETFs, broad semi ETFs, single-name exposure), and discuss whether the momentum is sustainable or a setup for mean reversion. The tone is flexible—part celebration, part caution, part analysis—because the milestone is both an achievement and a warning. Achievement: thematic investing has matured. Warning: when something grows this fast, gravity eventually wins.
The DRAM ETF tracks an index of companies with meaningful DRAM revenue exposure—defined as at least 20% of trailing twelve-month revenue from DRAM-related products (commodity DRAM, HBM, graphics DRAM, automotive DRAM). The fund is market-cap-weighted, caps individual constituents at 25% of assets, rebalances quarterly, and charges 0.39% in annual fees. It's listed on NYSE Arca, trades in USD, and settles T+1 like any other U.S. ETF.
The index includes 8-12 names, dominated by the DRAM oligopoly:
The result is a fund that's 70-75% Samsung + SK Hynix + Micron, 10-15% smaller DRAM makers, and 10-15% equipment. It's concentrated, but not absurdly so—more focused than SMH, less concentrated than a single-name position.
Since launch in early 2025, the DRAM ETF has returned 85-100% (annualized 55-65%), driven by:
The ETF outperformed SMH by 25-30% over 18 months, SOXX by 30-35%, and the S&P 500 by 60-70%. It's the best-performing semiconductor ETF of the cycle—by a wide margin.
The DRAM ETF's success isn't accidental. It solved real problems for investors:
Before the DRAM ETF, investors had two choices: buy broad semiconductor ETFs (SMH, SOXX) and accept dilution (NVIDIA, AMD, Broadcom dominate), or buy single-name DRAM stocks (Samsung, SK Hynix, Micron) and accept idiosyncratic risk. The DRAM ETF offered a third option: pure DRAM beta, diversified across the oligopoly.
For investors who believed DRAM—specifically HBM—was the critical bottleneck in AI infrastructure, this was the cleanest vehicle available. No software, no foundries, no equipment dilution (beyond the 10-15% allocation). Just DRAM.
Single-name DRAM exposure requires trading Samsung (KRX:005930) or SK Hynix (KRX:000660) directly—challenging for U.S. investors due to KRW settlement, trading hours, and custody friction. Micron (MU) is U.S.-listed, but it's only 20% of the DRAM market. The DRAM ETF is USD-denominated, trades during U.S. hours, settles T+1, and is eligible for U.S. tax-deferred accounts (IRAs, 401(k)s).
Liquidity is deep: average daily volume of $200-400 million, bid-ask spreads of 1-3 bps for standard orders. Institutions can move $50-100 million without meaningful slippage. Retail investors can trade size without worrying about liquidity.
The ETF launched at the perfect moment: early 2025, just as HBM demand was accelerating, DDR5 was transitioning, and AI server content was ramping. Investors were looking for AI exposure, but NVIDIA was up 300% from 2023-2024 and felt expensive. DRAM was the next best thing—AI-leveraged, but not yet fully priced in.
The ETF captured the wave. It didn't create the wave—it rode it. But timing matters. Launch 12 months earlier (2024), and the ETF might have struggled to gather assets. Launch 12 months later (2026), and the HBM rally might have been fully priced. Early 2025 was the sweet spot.
How does the DRAM ETF compare to other AI storage and computing themed products?
The Korean HBM ETF (KRX:HBM) is purer on HBM (55-65% SK Hynix + Samsung, both HBM leaders), but less diversified (no Micron, limited equipment exposure). It's also KRW-denominated, less liquid ($30-50 million ADV), and less accessible for U.S. investors. The DRAM ETF is broader (commodity DRAM + HBM), more liquid, and more accessible—but slightly less pure on HBM.
For investors who want maximum HBM beta, the Korean HBM ETF wins. For investors who want DRAM exposure (HBM + commodity + DDR5) with U.S. liquidity, the DRAM ETF wins.
SMH and SOXX include DRAM exposure (Micron, Samsung ADR, SK Hynix ADR), but diluted—DRAM is 10-15% of SMH, less of SOXX. The DRAM ETF is 70-75% DRAM makers, 10-15% DRAM equipment. For investors who want DRAM beta without dilution, the DRAM ETF wins. For investors who want broad semi exposure with some DRAM, SMH/SOXX win.
Performance-wise, the DRAM ETF outperformed SMH by 25-30% over 18 months. But it also underperformed during broad semi rallies when DRAM lagged (e.g., Q2 2025, when NVIDIA earnings drove SMH up 15% while DRAM was flat). The DRAM ETF is higher beta, higher volatility.
Micron (MU) is U.S.-listed, liquid, and pure DRAM. But it's only 20% of the DRAM market. The DRAM ETF includes Samsung and SK Hynix (80% of the market). For investors who want full DRAM oligopoly exposure, the ETF wins. For investors who want U.S. content, government subsidies (CHIPS Act), and single-name leverage, Micron wins.
Performance-wise, Micron outperformed the DRAM ETF by 10-15% over 18 months (Micron up 100-110%, ETF up 85-100%). But Micron also had higher volatility (60-70% annualized vs. ETF's 45-50%). The ETF is smoother, more diversified.
The DRAM ETF's strengths are also its weaknesses. Concentration creates beta, but it also creates volatility. Thematic purity captures DRAM upside, but it also exposes investors to DRAM-specific downside. Liquidity is deep, but it can vanish in stress. And perhaps most critically: DRAM is cyclical. What goes up must come down—or at least consolidate.
DRAM is memory. Memory is cyclical. HBM may have higher growth and better pricing than commodity DRAM, but it's still subject to supply-demand imbalances. When hyperscalers over-order DRAM (as they did in Q4 2024), inventory builds, ASPs fall, and margins compress. The ETF will fall 40-60% in a downcycle—just like Micron or SK Hynix.
Mitigation: Monitor inventory days, DRAM lead times, and hyperscaler capex guidance. When inventory exceeds 12-14 weeks or lead times fall below 8-10 weeks, reduce exposure. Don't hold through the full cycle.
Samsung, SK Hynix, and Micron represent 70-75% of the fund. This isn't diversification—it's a three-name bet with satellite exposure. If Samsung faces yield issues on HBM3E, or SK Hynix loses NVIDIA share, or Micron delays HBM4, the ETF falls 15-25% in a week. Single-name risk is real, even in an "ETF."
Mitigation: Cap position size. Don't allocate more than 10-15% of a portfolio to the DRAM ETF, even if conviction is high. Use it as a satellite holding, not a core position.
Thematic ETFs attract momentum investors. When DRAM is hot, flows pour in, pushing the ETF premium to NAV (net asset value) to 2-4%. When DRAM cools, flows reverse, pushing the discount to NAV to 2-4%. The ETF can underperform the underlying index by 4-8% annually due to flow-driven premiums and discounts.
Mitigation: Monitor premium/discount to NAV daily. Don't buy when the ETF is at a 2%+ premium. Don't sell when it's at a 2%+ discount. Use limit orders, not market orders, to avoid paying the spread.
DRAM isn't the only path to high-bandwidth memory. CPO (co-packaged photonics), optical interconnects, and new memory architectures (MRAM, ReRAM) could displace DRAM over the next 5-10 years. If technology shifts, the ETF becomes a legacy bet—like a DRAM ETF in the 2010s, when NAND became the growth story.
Mitigation: Monitor technology roadmaps (JEDEC standards, OIF standards, academic research). If HBM4 is delayed or if CPO gains meaningful traction, reduce exposure. Don't assume DRAM is the end state.
The DRAM ETF's success has implications for the broader AI storage and computing ETF ecosystem:
The $10B milestone proves that investors want pure thematic exposure—not diluted broad-market products. Expect more niche ETFs: NAND ETF, HBM ETF (U.S.-listed), CoPoS ETF, AI Server ETF, Advanced Packaging ETF. The market is signaling demand for specificity.
The DRAM ETF's deep liquidity ($200-400 million ADV) attracts more investors, which creates more liquidity, which attracts more investors. It's a virtuous cycle. New thematic ETFs will struggle to replicate this—they need critical mass ($1-2B AUM) before liquidity becomes self-sustaining. The DRAM ETF got lucky with timing and theme. Others may not.
The DRAM ETF's 85-100% return in 18 months attracted performance chasers—investors who buy what's hot, not what's cheap. This is unsustainable. When DRAM enters a downcycle (and it will), flows will reverse, and the ETF will underperform. Investors who bought at the top will be disappointed. This is the ETF lifecycle: launch, growth, euphoria, mean reversion. The DRAM ETF is in the euphoria phase. Mean reversion is coming.
For investors who understand the risks, several strategies emerge:
Use the DRAM ETF as a satellite holding (5-15% of portfolio) within a broader AI infrastructure or semiconductor allocation. Core: broad semi ETF (SMH, SOXX) or AI-themed ETF (AIQ, IRBO). Satellite: DRAM ETF for pure DRAM beta. Rebalance quarterly to maintain target weights.
Best for: Long-term investors who want DRAM exposure without single-name risk. Suitable for taxable accounts (ETF structure is tax-efficient vs. direct equity).
Overweight the DRAM ETF when DRAM fundamentals are strong (inventory below 10-12 weeks, lead times above 12-14 weeks, ASPs rising 5-10% QoQ). Underweight or short when fundamentals weaken (inventory above 14-16 weeks, lead times falling, ASPs flat or declining). Use the ETF for tactical tilts, not static allocations.
Best for: Active investors who monitor DRAM supply-demand dynamics. Requires quarterly (or monthly) rebalancing based on fundamental signals.
When DRAM fundamentals are stronger than NAND fundamentals (e.g., DRAM inventory drawing while NAND inventory building, DRAM ASPs rising while NAND ASPs flat), go long DRAM ETF and short NAND ETF (if/when available). This isolates DRAM beta from NAND beta.
Best for: Relative value investors who want to express DRAM outperformance without taking market beta. Requires margin account and short-selling capability.
Buy the DRAM ETF and sell covered calls (1-3 month expiries, 5-10% OTM) to generate income. Or buy protective puts (3-6 month expiries, 10-15% OTM) to hedge downside. Options enhance returns or define risk, depending on the view.
Best for: Income-focused investors (covered calls) or risk-averse investors (protective puts). Requires options approval and understanding of Greeks.
The DRAM ETF's $10B milestone is a watershed moment for thematic investing. It proves that investors want specificity, liquidity, and accessibility. It proves that niche themes—when timed correctly—can gather assets faster than broad-market products. And it proves that the ETF ecosystem is maturing: from broad indices to sector funds to thematic sleeves to single-theme pure plays.
But it's also a warning. Thematic ETFs attract momentum. When DRAM is hot, the ETF will surge. When DRAM cools, the ETF will crater. The investors who thrive won't be those who buy and hold—they'll be those who understand the cycle, monitor the fundamentals, and adjust exposure accordingly.
DRAM is not a buy-and-hold theme. It's a cycle to be navigated. The ETF is the vehicle. The discipline is yours.
The DRAM ETF crossed $10B in 18 months. It's the fastest-growing semiconductor ETF in history. It's concentrated, cyclical, and correlated to Samsung, SK Hynix, and Micron. It's also liquid, accessible, and diversified within the theme. For investors who understand the risks and have the discipline to manage them, it's the best DRAM vehicle available. For investors who chase themes without understanding the underlying dynamics, it's a wealth destruction machine.
The choice is clear. The tool is available. The question is whether you'll use it wisely.
DRAM is the bottleneck. The ETF is the key. Turn it.